the daily intakes of 2-amino-3,4,8-trimethylimidazo[4,5â€”f]quinoxaline (dimeiqx) and benzo(a)pyrene (bap), as well as the mutagenic activity, were significant predictors for pancreatic cancer (p = 0.008, 0.031, and 0.029, respectively) with adjustment of other confounders.